1 / 10

Opioid Use Disorder Performance Incentive Criteria

This program aims to address barriers and challenges in accessing treatment for individuals with opioid use disorder. Providers must outline their policies and procedures in four key areas: provision of MAT, access and staffing, customer service and cultural responsiveness, and marketing. Eligible providers can apply for a $50,000 performance award to implement strategies by September 30, 2018.

robinsons
Télécharger la présentation

Opioid Use Disorder Performance Incentive Criteria

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opioid Use Disorder Performance Incentive Criteria Criteria was developed in direct response to most commonly reported access barriers and challenges • Stories of individuals reporting they were “denied” treatment, however they were never presented to CBH for authorization • Turned away by providers due to various challenges Key Charge is Access • Making sure individuals are getting in the door and connected to appropriate treatment and services

  2. Opioid Use Disorder Performance Incentive Criteria Applicants must outline their policies and procedures for the bullet points in each of the four sections: • Provision of MAT • Access and Staffing • Customer Service and Cultural Responsiveness • Marketing

  3. I. Provision of MAT Barriers/Challenges: • Waiting in withdrawal for hours and told to return the next day • Turned away due to UDS positive for multiple substances • Turned away due to negative UDS, but evidence of use and withdrawal from fentanyl • Turned away and/or waiting for supplemental documentation from prior treatment programs Key items: • Direct provision and induction of MAT (a minimum of 2 of the 3 forms, i.e. buprenorphine and methadone OR buprenorphine and vivitrol, etc.) • Alignment with DDAP Policy Bulletin No. 18-04 – initiate treatment upon “completion” • Initiate treatment with UDS positive for multiple substances (i.e. benzodiazepines, methadone, etc.)

  4. II. Access and Staffing Barriers/Challenges: • Limited prescriber days/times; individuals told to return another day when prescriber will be on site to initiate MAT • Turned away due to lack of identification • Turned away due to medical issues • Turned away without being connected to other services (i.e. BHSI Case Management) • Lack of discussion and education on clinically appropriate treatment Key items: • Offer walk-in and open access during non-traditional work hours • Ensure prescriber capability spans across operating hours/days • DBHIDS recommended guidance for confirming ID • Level of care recommendations based on clinical assessment and mutually determined with educating individuals on clinically appropriate treatment recommendations

  5. III. Customer Service and Cultural Responsiveness Barriers/Challenges: • Waiting an hour before being greeted by staff; unstaffed front desks • Security and frontline staff dissuading individuals to seek treatment by highlighting potential barriers and/or false information about other programs • Degrading language and interactions with individuals seeking help/in withdrawal • Using drug-free and abstinence language instead of medication free Key items: • Dedicated front desk/engagement staff • Ensure assessments are completed within two hours of arrival to facility • Document outcomes for all individuals who enter the facility • Customer service policy promoting recovery, engagement, empathy, compassion, understanding, patience, and evidence-based practices for all staff levels

  6. IV. Marketing Barriers/Challenges: • Transportation • Unaware of open access/walk-in hours Key items: • Provide transportation from neighborhood hotspots • Communication with advocates and outreach teams • Staff presence in the community

  7. Applicant Eligibility Currently a CBH contract provider Licensed Drug and Alcohol provider A provider in good standing Timely submission of completed proposal

  8. Key Dates • June 4, 2018 – Deadline for Submission of Questions • June 6, 2018 – Answers to Questions Posted on DBHIDS Website • June 22, 2018 – Proposals are Due by 2:00pm • June 27, 2018 – Provider Interviews if Necessary • July 2, 2018 – Selected Providers will be Posted on DBHIDS Website

  9. Provider Implementation • DBHIDS team will work with providers to develop a quality monitoring plan • All proposed provider strategies must be implemented by September 30, 2018 • First quality monitoring evaluation will occur on November 1, 2018, if strategies are not in place the provider will return the $50,000 performance award to CBH • Second quality monitoring evaluation will occur January 2, 2019 to explore effectiveness of strategies and sustainability plan

  10. Contact Information • All questions and requests should directed to Kim Doyle, Director of Provider Operations • Kimberly.doyle@phila.gov • 215-413-7648

More Related